We recently described a population-based case-control study in Guadeloupe among a Caribbean population of African descent showing that homozygous deletions of GSTM1 and those of GSTT1 are each, independently, significantly associated with a reduced risk of prostate cancer [14]. The gene discussed is GSTM1; the disease is prostate cancer.